COMMUNIQUÉS West-GlobeNewswire

HOOKIPA Pharma Reports First Quarter 2019 Financial Results and Recent Business Highlights
20/05/2019
NEW YORK and VIENNA, Austria, May 20, 2019 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (“HOOKIPA”), a company developing a new class of immunotherapeutics, targeting infectious diseases and cancers based on its proprietary [...]
CymaBay Therapeutics Presents Data in Patients with Primary Biliary Cholangitis at DDW 2019
20/05/2019
NEWARK, Calif., May 20, 2019 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a biopharmaceutical company focused on developing and providing access to innovative therapies for patients with liver and [...]
Align Technology General Counsel Retires After 17 Years, Appoints Julie Coletti SVP Chief Legal and Regulatory Officer
20/05/2019
SAN JOSE, Calif., May 20, 2019 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN), today announced that Roger E. George, Align senior vice president, chief legal and regulatory officer has retired and will leave [...]
AzurRx BioPharma Presents Positive Secondary Endpoint Data in its Phase II MS1819-SD Chronic Pancreatitis Study at the 2019 Digestive Disease Week Conference
20/05/2019
Statistical significance achieved on multiple secondary endpoints New data underscore the potential of MS1819 to provide meaningful clinical benefits to patients suffering from exocrine pancreatic insufficiency (EPI) [...]
Can-Fite BioPharma Announces $6 Million Registered Direct Offering
20/05/2019
PETACH TIKVA, Israel, May 20, 2019 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI) , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, [...]
HX Global SVP of Business Operations Attends Event Hosted by HRH Prince Charles of Wales
20/05/2019
Tim Crockett was present for the launch of HRH appeal to raise £10 million for Combat Stress LONDON, May 20, 2019 (GLOBE NEWSWIRE) -- HX Global’s Senior Vice President of Operations, Tim Crockett, had the honor of being [...]
Athersys Presents Data From Its Acute Respiratory Distress Syndrome Clinical Trial at American Thoracic Society International Conference
20/05/2019
The MultiStem® treatment group had more ventilator-free and ICU-free days, and greater reduction in acute inflammatory biomarkers compared to the placebo CLEVELAND, May 20, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. ( [...]
OSE Immunotherapeutics Receives Notice of Allowance for New U.S. Patent Protecting Anti-IL-7 Receptor Antagonist OSE-127
20/05/2019
The new patent will cover OSE-127 through 2035 NANTES, France, May 20, 2019 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics (ISIN: FR0012127173; Mnémo: OSE) today announces that it has received the first notice of allowance [...]
Arcturus Therapeutics Presenting Data for ARCT-810 and the Arcturus mRNA + LUNAR® Technology Platform at the 2019 Annual Meeting of TIDES: Oligonucleotide and Peptide Therapeutics
20/05/2019
SAN DIEGO, May 20, 2019 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ: ARCT) (the “Company”), a leading messenger RNA medicines company focused on the discovery, development and commercialization of [...]
Verona Pharma Presents Expanded Analysis of Ensifentrine Clinical Data in COPD Maintenance Treatment at American Thoracic Society 2019 International Conference
20/05/2019
Analysis confirms continued symptom benefits improving over time, supporting anti-inflammatory effects of ensifentrine in addition to bronchodilation LONDON, May 20, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP [...]
Innovate Biopharmaceuticals Announces Presentation of Three Posters Focusing on the Molecular Biology and Pharmacology of Larazotide at the 2019 Digestive Disease Week Conference in San Diego
20/05/2019
Analyst Meeting to be held at 4:30pm ET today to discuss NASH data and provide clinical updates Three posters presented at DDW 2019 highlighted the protective effect and molecular mechanism of action of larazotide [...]
Transactions under Novozymes’ stock buyback program
20/05/2019
Please read the full announcement in the attached PDF Attachment 2019_13_Stock_Buybackprogram_EN
TOMI Environmental Solutions, Inc. Reports First Quarter Financial Results
20/05/2019
BEVERLY HILLS, Calif., May 20, 2019 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. ® (“TOMI”) (OTCQX:TOMZ), a global company specializing in disinfection and decontamination essentials, announced its results for [...]
SetPoint Medical Reports New Data Demonstrating its Bioelectronic Medicine Effectively Reduces Crohn’s Disease Activity
20/05/2019
Results Delivered in Oral Presentation at Digestive Disease Week 2019 VALENCIA, Calif., May 20, 2019 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic [...]
Auris Medical Holding Ltd Regains Compliance with Nasdaq Minimum Bid Price Rule
20/05/2019
Hamilton, Bermuda, May 20, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and [...]
Merus to Present at the RBC Capital Markets 2019 Healthcare Conference
20/05/2019
UTRECHT, Netherlands, May 20, 2019 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, “we”, “our” or the “Company”), a clinical-stage immuno-oncology company developing Biclonics®, innovative full-length human [...]
Teladoc Health Establishes First and Only Patient Safety Organization (PSO) for Virtual Care
20/05/2019
Listed through the Agency for Healthcare Research and Quality HHS, the PSO will develop and execute industry-leading quality and safety initiatives PURCHASE, NY, May 20, 2019 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: [...]
AIT Therapeutics Announces Oral and Poster Presentations at the International Society for Aerosols in Medicine 2019 Congress in Montreux, Switzerland
20/05/2019
GARDEN CITY, N.Y. and REHOVOT, Israel, May 20, 2019 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (NASDAQ: AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO [...]
Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties
20/05/2019
Valby, Denmark, 20 May 2019 – H. Lundbeck A/S (Lundbeck) hereby publishes and reports transactions made by executives and persons closely associated with them with shares and linked securities in Lundbeck. 1. Details of [...]

Pages